Today's drug development landscape demands the latest technologies, advanced capabilities, and above all flexibility. From overcoming development and manufacturing complexities to working faster and smarter, CDMOs provide the flexibility needed to meet ever-changing drug development needs providing therapeutic expertise and sophisticated capabilities to help advance drugs to market.
This CDMO Showcase highlights companies that excel in supporting pharma innovators, helping them meet aggressive timelines and achieve stronger financial outcomes.
Abzena is the leading end-to-end CDMO + CRO for bioconjugates & complex biologics (ADCs, AOCs, RDCs, Bi/Multi-specifics). From discovery through commercial, we support customers with fully integrated programs or individual services that reduce risk and streamline programs to IND and beyond. With over 25 years of experience, 2,000+ conjugates developed, and footholds in the US and UK, we provide a simplified & secure supply chain.
